Sedation and Analgesia in Intensive Care : A Comparison of Fentanyl and Remifentanil

Abstract EN

Optimal sedation and analgesia are of key importance in intensive care.

The aim of this study was to assess the quality of sedoanalgesia and outcome parameters in regimens containing midazolam and either fentanyl or remifentanil.

A prospective, randomized, open-label, controlled trial was carried out in the ICU unit of a large teaching hospital in Istanbul over a 9-month period.

Thirty-four patients were randomly allocated to receive either a remifentanil-midazolam regimen (R group, n=17) or a fentanyl-midazolam regimen (F group, n=17).

A strong correlation between Riker Sedation-Agitation Scale (SAS) and Ramsey Scale (RS) measurements was observed.

Comparatively, remifentanil provided significantly more potent and rapid analgesia based on Behavioral-Physiological Scale (BPS) measurements and a statistically nonsignificantly shorter time to discharge.

On the other hand, remifentanil also caused a significantly sharper fall in heart rate within the first six hours of treatment.